Literature DB >> 12767452

Childhood and juvenile onset multiple sclerosis: clinical and paraclinical features.

Serkan Ozakbas1, Egemen Idiman, Baris Baklan, Burak Yulug.   

Abstract

It is well known that multiple sclerosis (MS) is a demyelinating disease of the central nervous system that mostly starts in the second to third decade. In the present study, we reviewed our own observations of the clinical and paraclinical features in the 36 of 890 (4.04%) MS patients whose symptoms started before 16 years of age. The average age at onset of the disease in these 36 patients was 12.9 years. In 18 patients, the disease onset was monosymptomatic. Diplopia and sensory disturbances were the most common initial manifestations and occurred in 27.7% of cases. Twenty-one patients (59%) had a relapsing and 11 patients (30.5%) had a secondary progressive course. On the last evaluation, the EDSS score was above 5 in 11 patients and it was below 5 in 21 patients. As a result of this study, we concluded that childhood onset MS does not significantly differ from that it has been typically seen in adults in terms of major clinical manifestations and course of disease.

Entities:  

Mesh:

Year:  2003        PMID: 12767452     DOI: 10.1016/s0387-7604(03)00034-2

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  16 in total

1.  Childhood multiple sclerosis and related disorders.

Authors:  Amna Al-Futaisi
Journal:  Oman Med J       Date:  2007-10

Review 2.  Imaging in Pediatric Demyelinating and Inflammatory Diseases of the Brain- Part 1.

Authors:  Sniya Valsa Sudhakar; Karthik Muthusamy; Sunithi Mani; Sridhar Gibikote; Manohar Shroff
Journal:  Indian J Pediatr       Date:  2015-12-04       Impact factor: 1.967

3.  Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: results of a nationwide survey.

Authors:  Daniela Pohl; Isabell Hennemuth; Rüdiger von Kries; Folker Hanefeld
Journal:  Eur J Pediatr       Date:  2007-01-12       Impact factor: 3.183

4.  Characteristics of Children and Adolescents With Multiple Sclerosis.

Authors:  Anita L Belman; Lauren B Krupp; Cody S Olsen; John W Rose; Greg Aaen; Leslie Benson; Tanuja Chitnis; Mark Gorman; Jennifer Graves; Yolander Harris; Tim Lotze; Jayne Ness; Moses Rodriguez; Jan-Mendelt Tillema; Emmanuelle Waubant; Bianca Weinstock-Guttman; T Charles Casper
Journal:  Pediatrics       Date:  2016-07       Impact factor: 7.124

Review 5.  Pediatric multiple sclerosis.

Authors:  E Ann Yeh; Tanuja Chitnis; Lauren Krupp; Jayne Ness; Dorothée Chabas; Nancy Kuntz; Emmanuelle Waubant
Journal:  Nat Rev Neurol       Date:  2009-10-13       Impact factor: 42.937

Review 6.  Seizures in patients with multiple sclerosis: epidemiology, pathophysiology and management.

Authors:  Brendan J Kelley; Moses Rodriguez
Journal:  CNS Drugs       Date:  2009-10       Impact factor: 5.749

7.  Pediatric multiple sclerosis.

Authors:  Yashma Patel; Vikram Bhise; Lauren Krupp
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

8.  Extensive acute axonal damage in pediatric multiple sclerosis lesions.

Authors:  Sabine Pfeifenbring; Reem F Bunyan; Imke Metz; Christian Röver; Peter Huppke; Jutta Gärtner; Claudia F Lucchinetti; Wolfgang Brück
Journal:  Ann Neurol       Date:  2015-02-26       Impact factor: 10.422

9.  Paediatric multiple sclerosis: the experience of the German Centre for Multiple Sclerosis in Childhood and Adolescence.

Authors:  Wiebke Stark; Peter Huppke; Jutta Gärtner
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

10.  Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: long-term results.

Authors:  A Ghezzi; M P Amato; M Capobianco; P Gallo; M G Marrosu; V Martinelli; C Milanese; L Moiola; N Milani; L La Mantia; F Patti; C Pozzilli; M Trojano; G Comi; M Zaffaroni
Journal:  Neurol Sci       Date:  2007-06-30       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.